Description

Join us for an insightful interview with Dr. Megan Baldwin, Founder and Chief Innovation Officer at Opthea.

In this conversation, Dr. Baldwin shares her journey in pioneering biotech innovation, the development of groundbreaking therapies for eye diseases, and the challenges and successes of taking a company from early-stage research to late-stage clinical trials.

Learn about the impact of Opthea’s lead asset on improving patients' vision and quality of life, and gain valuable insights for aspiring biotech entrepreneurs.

Table Of Contents

Origin of the technology and Dr. Baldwin's early involvement
Challenges and motivations behind founding Opthea
Timeline and expectations for Opthea's drug approval and commercialization
0
Your cart